Good morning, in this edition of Archer’s Newsletter, we highlight the recent technological achievements by the Archer team, with outstanding progress made in the development of the 12CQ quantum chip and Archer’s biochip.
By applying clever computational quantum chemistry methods, we were able to use supercomputers to pinpoint the origins of the observed metallic-like properties in the 12CQ qubit material.
This is important work because it validates the uniqueness of the 12CQ qubit material, which is a key part of our internationally patented qubit technology architecture.
The supercomputing machines are housed in Switzerland, and we worked with our colleagues at EPFL, a world-class tech institute in Switzerland, to access these incredibly powerful computers to perform the complex modelling and simulations of the qubit material.
We have also made great strides in biochip development. The Archer team recently fabricated a graphene field effect transistor (gFET) that operates in a liquid environment. Significant innovation was involved in the design and operation of the wettable gFET.
The gFET is the biochip sensing component that will be used for digitising biologically relevant signals, like those from viruses or bacteria. We then incorporated the gFETs into an end-to-end, seamlessly integrated, prototype system platform for electronic biosensing.
The system platform was implemented in such a way that would allow the Archer team to collect the biochip tech-related data they need to establish partnerships with global companies operating in the MedTech space.
When we think about growing Archer in the long-term, it is currently about developing advanced semiconductors like no other, in a methodical, consistent, high-quality way.
We continue to make meaningful progress and I'm excited about the opportunities that lie ahead of us.
Dr Mohammad Choucair, FRACI FRSN GAICD
Chief Executive Officer
Archer Materials Limited (ASX: AXE)
Designed by Aaron Knight.